Header menu link for other important links
X
Enzyme therapy: a forerunner in catalyzing a healthy society?
S. Datta, K.N. Rajnish, , S. Melvin Samuel, E. Selvarajan, H. Zayed
Published in Taylor and Francis Ltd.
2020
PMID: 32597245
Pages: 1151 - 1174
Abstract
Introduction: The use of enzymes in various industries has been prevalent for centuries. However, their potency as therapeutics remained latent until the late 1950 s, when scientists finally realized the gold mine they were sitting on. Enzyme therapy has seen rapid development over the past few decades and has been widely used for the therapy of myriad diseases, including lysosomal storage disorders, cancer, Alzheimer’s disease, irritable bowel syndrome, exocrine pancreatic insufficiency, and hyperuricemia. Enzymes are also used for wound healing, the treatment of microbial infections, and gene therapy. Areas covered: This is a comprehensive review of the therapeutic use of enzymes that can act as a guidepost for researchers and academicians and presents a general overview of the developments in enzyme therapy over the years, along with updates on recent advancements in enzyme therapy research. Expert opinion: Although enzyme therapy is immensely beneficial and induces little auxiliary damage, it has several drawbacks, ranging from high cost, low stability, low production, and hyperimmune responses to the failure to cure a variety of the problems associated with a disease. Further fine-tuning and additional clinical efficacy studies are required to establish enzyme therapy as a forerunner to catalyzing a healthy society. © 2020, © 2020 Informa UK Limited, trading as Taylor & Francis Group.
About the journal
JournalData powered by TypesetExpert Opinion on Biological Therapy
PublisherData powered by TypesetTaylor and Francis Ltd.
ISSN14712598